Elotuzumab for Treatment of Multiple Myeloma (Literature Review)
Chemotherapy has been the main treatment option for multiple myeloma for several decades. However, a considerable increase in the life expectancy was observed in multiple myeloma patients when thalidomide, bortezomib and lenalidomide had been introduced into clinical practice. Nevertheless, the dise...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Artigo |
| Sprache: | Russo |
| Veröffentlicht: |
Practical Medicine Publishing House
2016-10-01
|
| Schriftenreihe: | Клиническая онкогематология |
| Schlagworte: | |
| Online-Zugang: | https://bloodjournal.ru/index.php/coh/article/view/513 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|